Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALPG | P10696 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30697691 | 1.00 | HTR2C (0.44) | HTR2CHTR2BMAPTMEN1KMT2A | |
| SCHEMBL8862470 | 0.82 | HTR2C (0.45) | HTR2CHTR2BMAPTMEN1KMT2A | |
| SCHEMBL8862518 | 0.78 | MAPT (0.40) | HTR2CHTR2BMAPTMEN1KMT2A | |
| SCHEMBL8680760 | 0.78 | MEN1 (0.50) | MAPTMEN1KMT2AALDH1A1NPSR1 | |
| SCHEMBL29592742 | 0.78 | MEN1 (0.33) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL8871056 | 0.77 | HTR2C (0.46) | HTR2CHTR2BMAPTMEN1KMT2A | |
| SCHEMBL8680106 | 0.74 | MAPT (0.39) | MAPTMEN1KMT2AALDH1A1HTT | |
| SCHEMBL8681103 | 0.73 | KDM4E (0.50) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL381889 | 0.71 | HTR2C (0.52) | HTR2CHTR2BMAPTMEN1KMT2A | |
| SCHEMBL8887017 | 0.69 | MAPT (0.33) | MAPTMEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6551710-B1 | Primer composition comprises dithiol or polythiol compound and allyl or vinyl monomer; coating composition can further comprise photochromic dyes and additional polymerizable monomers; coatings for lenses | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 2003-04-22 | — | — | US | claimed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| WO-1997027223-A1 | PROCESS FOR PREPARING OPTICAL ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1997-07-31 | — | — | WO | claimed |
| US-12600879-B2 | Coated lens and method for manufacturing the same | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-4493966-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | Carl Zeiss Vision International GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| US-20240417588-A1 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| EP-3488287-B1 | PRINTING INK, PREFERABLY 3D PRINTING INK, SPECTACLE LENS, AND METHOD FOR MANUFACTURING AN EYEGLASS LENS | ZEISS CARL VISION INT GMBH (DE) | 2023-12-20 | — | — | EP | disclosed |
| WO-2023175193-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2023-09-21 | — | — | WO | disclosed |
| US-11754860-B2 | Photochromic lens with laminated film, method for producing a photochromic lens, and a spectacle frame | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2023-09-12 | — | — | US | disclosed |
| US-20210156739-A1 | Wearable UV Exposure Sensor | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2021-05-27 | — | — | US | disclosed |
| US-20200201079-A1 | PHOTOCHROMIC LENS WITH LAMINATED FILM, METHOD FOR PRODUCING A PHOTOCHROMIC LENS, AND A SPECTACLE FRAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| EP-0822948-A1 | TINTABLE CROSS-LINKABLE COMPOSITIONS | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 1998-02-11 | — | — | EP | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| EP-0797786-A1 | INCORPORATING PHOTOCHROMIC MOLECULES IN LIGHT TRANSMISSIBLE ARTICLES | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 1997-10-01 | — | — | EP | disclosed |
| WO-1997027223-A1 | PROCESS FOR PREPARING OPTICAL ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1997-07-31 | — | — | WO | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1996034025-A1 | TINTABLE CROSS-LINKABLE COMPOSITIONS | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1996-10-31 | — | — | WO | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| WO-1996018928-A1 | INCORPORATING PHOTOCHROMIC MOLECULES IN LIGHT TRANSMISSIBLE ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1996-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600879-B2 | Coated lens and method for manufacturing the same | GMFG, AQP4, METTL14 | HTR2C 2276/4885HTR2B 3892/4885MAPT 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.